{"title":"Predictive cavity and binding site identification: Techniques and applications.","authors":"Shilpa Chandel, Bharat Parashar, Syed Atif Ali, Shailesh Sharma","doi":"10.1016/bs.apha.2025.02.006","DOIUrl":null,"url":null,"abstract":"<p><p>Strategies for recognizing predictive cavities and binding site identification are decisive for drug discovery, molecular docking, and tracing protein-ligand interactions. The two major approaches experimental and computational strive for prognosticating and distinguishing protein's binding sites. Profuse diminutive molecules are associated with the binding sites and influence normal biological functioning. The various structure-based strategies such as molecular dynamics, docking simulations, algorithms for pocket identification, and homology modeling are covered under computational techniques, where they propound the exhaustive comprehension of possible binding pockets hinge on the structure of protein and its physiochemical properties. The various sequence-based approaches rely on the homogeneousness of the sequence and machine learning replicas edified on already known protein and ligand composites to anticipate the interactive sites of novel proteins. The high-resolution structural identification and foot printing of protein to map the confirmational changes attributable to ligand and binding sites can be identified through diverse experimental methods such as NMR spectroscopy, mass spectrometry, and x-ray crystallography. These techniques are pivotal for drug discovery and designing, as the efficiency and specificity of ligands can be amplified through virtual screening and structural-based drug designing. Moreover, the ongoing developments in this domain promise to drive the revolution and efficiency in drug discovery and research in molecular biology.</p>","PeriodicalId":7366,"journal":{"name":"Advances in pharmacology","volume":"103 ","pages":"43-63"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/bs.apha.2025.02.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/28 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Strategies for recognizing predictive cavities and binding site identification are decisive for drug discovery, molecular docking, and tracing protein-ligand interactions. The two major approaches experimental and computational strive for prognosticating and distinguishing protein's binding sites. Profuse diminutive molecules are associated with the binding sites and influence normal biological functioning. The various structure-based strategies such as molecular dynamics, docking simulations, algorithms for pocket identification, and homology modeling are covered under computational techniques, where they propound the exhaustive comprehension of possible binding pockets hinge on the structure of protein and its physiochemical properties. The various sequence-based approaches rely on the homogeneousness of the sequence and machine learning replicas edified on already known protein and ligand composites to anticipate the interactive sites of novel proteins. The high-resolution structural identification and foot printing of protein to map the confirmational changes attributable to ligand and binding sites can be identified through diverse experimental methods such as NMR spectroscopy, mass spectrometry, and x-ray crystallography. These techniques are pivotal for drug discovery and designing, as the efficiency and specificity of ligands can be amplified through virtual screening and structural-based drug designing. Moreover, the ongoing developments in this domain promise to drive the revolution and efficiency in drug discovery and research in molecular biology.